跳至主要内容
临床试验/ACTRN12620000802909
ACTRN12620000802909已完成未知

Analysis of Patient Outcomes following Platelet Rich Plasma Treatmentfor Joint Osteoarthritis

Surecell Medical Clinic0 个研究点目标入组 1,078 人开始时间: 2020年8月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,078

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Were 18 years and over of age.
  • They received PRP treatment for pain and/or loss of function due to knee OA.
  • They received PRP treatment for pain and/or loss of function due to pes anserine bursitis.
  • They received PRP treatment for pain and/or loss of function due to ankle osteoarthritis.
  • They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament sprain.
  • They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament tear.

排除标准

  • Were under 18 years of age.
  • Were immuno-compromised.
  • Had a current malignancy.
  • Had a current or recent joint infection.
  • Had taken non-steroidal anti-inflammatory drugs 2 days before treatment or corticosteroids during the three weeks before treatment.
  • Were pregnant or breastfeeding.

研究者

发起方
Surecell Medical Clinic

相似试验

Analysis of Patient Outcomes following Platelet Rich... | 临床试验